These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10791084)

  • 41. Anti-B-series ganglioside-recognizing autoantibodies in an acute sensory neuropathy patient cause cell death of rat dorsal root ganglion neurons.
    Ohsawa T; Miyatake T; Yuki N
    Neurosci Lett; 1993 Jul; 157(2):167-70. PubMed ID: 8233048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High affinity of anti-GM1 antibodies is associated with disease onset in experimental neuropathy.
    Comín R; Yuki N; Lopez PH; Nores GA
    J Neurosci Res; 2006 Oct; 84(5):1085-90. PubMed ID: 16881049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N
    J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
    Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
    Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Anti-glycolipid antibodies in the diagnosis of autoimmune neuropathies].
    Willison HJ
    Rev Neurol (Paris); 2002 Dec; 158(123):16-20. PubMed ID: 12690328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
    Shu XM; Cai FC; Zhang XP
    Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Screening for anti-glycolipid antibody profiles from patients with immune-mediated peripheral neuropathies by Dotzen Ganglio Profile Antibodies].
    Caudie C; Reymond A; Antoine JC; Petiot P; Gonnaud PM; Vial C
    Ann Biol Clin (Paris); 2006; 64(2):149-56. PubMed ID: 16556525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b.
    Marfia GA; Pachatz C; Terracciano C; Leone G; Bernardini S; Bernardi G; Massa R
    Neurol Sci; 2005 Dec; 26(5):355-7. PubMed ID: 16388373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies to fucogangliosides in neurological diseases.
    Yuki N; Ariga T
    J Neurol Sci; 1997 Sep; 150(1):81-4. PubMed ID: 9260862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ataxic form of Guillain-Barré syndrome associated with anti-GD1b IgG antibody].
    Ichikawa H; Susuki K; Yuki N; Kawamura M
    Rinsho Shinkeigaku; 2001 Aug; 41(8):523-5. PubMed ID: 11889840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
    Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome.
    Caporale CM; Capasso M; Luciani M; Prencipe V; Creati B; Gandolfi P; De Angelis MV; Di Muzio A; Caporale V; Uncini A
    J Neuroimmunol; 2006 May; 174(1-2):12-20. PubMed ID: 16516981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postinfection sensory neuropathy associated with IgG anti-GD1b antibody.
    Yuki N; Hirata K
    Ann Neurol; 1998 May; 43(5):685-7. PubMed ID: 9585370
    [No Abstract]   [Full Text] [Related]  

  • 55. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A case of Guillain-Barré syndrome complicated with severe autonomic failure and presented elevated anti-GD1b and anti-GQ1b antibody].
    Inoue K; Kohriyama T; Ikeda J; Maruyama H; Nakamura S
    Rinsho Shinkeigaku; 2002 Jan; 42(1):13-7. PubMed ID: 12355845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new type of anti-ganglioside antibodies present in neurological patients.
    Lopez PH; Comín R; Villa AM; Di Egidio M; Saizar RD; Sica RE; Nores GA
    Biochim Biophys Acta; 2006 Mar; 1762(3):357-61. PubMed ID: 16410045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Autonomic involvement in Guillain-Barré syndrome].
    Kusunoki S
    Rinsho Shinkeigaku; 2006 Nov; 46(11):878-80. PubMed ID: 17432207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-ganglioside antibodies and the presynaptic motor nerve terminal.
    Willison HJ; Plomp JJ
    Ann N Y Acad Sci; 2008; 1132():114-23. PubMed ID: 18567860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ganglioside complexes as new target antigens in Guillain-Barré syndrome.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    Ann Neurol; 2004 Oct; 56(4):567-71. PubMed ID: 15389898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.